BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14558597)

  • 1. Differential expression of bikunin (HAI-2/PB), a proposed mediator of glioma invasion, by demethylation treatment.
    Schuster JM; Longo M; Nelson PS
    J Neurooncol; 2003 Sep; 64(3):219-25. PubMed ID: 14558597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
    Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells.
    Hamasuna R; Kataoka H; Meng JY; Itoh H; Moriyama T; Wakisaka S; Koono M
    Int J Cancer; 2001 Aug; 93(3):339-45. PubMed ID: 11433397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
    Parr C; Jiang WG
    Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatocyte growth factor regulatory factors in human breast cancer.
    Parr C; Watkins G; Mansel RE; Jiang WG
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):202-11. PubMed ID: 14734471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas.
    Kataoka H; Itoh H; Uchino H; Hamasuna R; Kitamura N; Nabeshima K; Koono M
    Cancer Lett; 2000 Feb; 148(2):127-34. PubMed ID: 10695988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma.
    Patel R; Shervington L; Lea R; Shervington A
    Brain Res; 2008 Jan; 1188():173-81. PubMed ID: 18021753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin.
    Suzuki M; Kobayashi H; Tanaka Y; Hirashima Y; Kanayama N; Takei Y; Saga Y; Suzuki M; Itoh H; Terao T
    Int J Cancer; 2003 Apr; 104(3):289-302. PubMed ID: 12569552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAGED4 expression in glioma and upregulation in glioma cell lines with 5-aza-2'-deoxycytidine treatment.
    Zhang QM; Shen N; Xie S; Bi SQ; Luo B; Lin YD; Fu J; Zhou SF; Luo GR; Xie XX; Xiao SW
    Asian Pac J Cancer Prev; 2014; 15(8):3495-501. PubMed ID: 24870746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor.
    Kawaguchi T; Qin L; Shimomura T; Kondo J; Matsumoto K; Denda K; Kitamura N
    J Biol Chem; 1997 Oct; 272(44):27558-64. PubMed ID: 9346890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
    Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
    Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of a hybrid gene consisting of the amino-terminal fragment of urokinase and carboxyl-terminal domain of bikunin suppresses invasion and migration of human ovarian cancer cells in vitro.
    Takei Y; Mizukami H; Saga Y; Kobayashi H; Suzuki M; Matsushita T; Ozawa K; Suzuki M
    Int J Cancer; 2005 Jan; 113(1):54-8. PubMed ID: 15386422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM; Pao MM; Jones PA
    Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions.
    Tung EK; Wong CM; Yau TO; Lee JM; Ching YP; Ng IO
    Int J Cancer; 2009 Apr; 124(8):1811-9. PubMed ID: 19107935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2.
    Pereira MS; Celeiro SP; Costa ÂM; Pinto F; Popov S; de Almeida GC; Amorim J; Pires MM; Pinheiro C; Lopes JM; Honavar M; Costa P; Pimentel J; Jones C; Reis RM; Viana-Pereira M
    Cell Oncol (Dordr); 2020 Feb; 43(1):107-121. PubMed ID: 31701492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
    Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
    Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
    Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
    Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tissue factor pathway inhibitor-2 in cancer biology.
    Sierko E; Wojtukiewicz MZ; Kisiel W
    Semin Thromb Hemost; 2007 Oct; 33(7):653-9. PubMed ID: 18000791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.